1 week Ago By Defense World Staff
Corebridge Financial Inc. trimmed its position in Pediatrix Medical Group, Inc. ( NYSE:MD – Free Report ) by 5.
3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 45,840 shares of the company’s stock after selling 2,590 shares during the quarter. Corebridge Financial Inc.
owned approximately 0.05% of Pediatrix Medical Group worth $601,000 at the end of the most recent reporting period. Several other institutional investors have also modified their holdings of MD.
Vanguard Group Inc. lifted its stake in Pediatrix Medical Group by 1.1% during the fourth quarter.
Vanguard Group Inc. now owns 10,812,611 shares of the company’s stock worth $141,861,000 after purchasing an additional 113,976 shares during the last quarter. LPL Financial LLC raised its holdings in Pediatrix Medical Group by 4.
9% during the fourth quarter. LPL Financial LLC now owns 92,828 shares of the company’s stock worth $1,218,000 after purchasing an additional 4,295 shares in the last quarter. KLP Kapitalforvaltning AS purchased a new stake in shares of Pediatrix Medical Group during the 4th quarter worth approximately $235,000.
AXQ Capital LP acquired a new position in shares of Pediatrix Medical Group in the 4th quarter valued at $180,000. Finally, American Century Companies Inc. grew its position in shares of Pediatrix Medical Group by 628.
2% in the 4th quarter. American Century Companies Inc. now owns 1,739,323 shares of the company’s stock valued at $22,820,000 after buying an additional 1,500,485 shares during the last quarter.
97.71% of the stock is owned by hedge funds and other institutional investors. Analyst Ratings Changes A number of equities research analysts recently weighed in on the stock.
Macquarie began coverage on shares of Pediatrix Medical Group in a research report on Monday, December 16th. They issued an “outperform” rating and a $18.00 price target for the company.
Truist Financial boosted their target price on Pediatrix Medical Group from $15.00 to $18.00 and gave the company a “hold” rating in a report on Friday, February 21st.
StockNews.com upgraded Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research note on Wednesday, January 22nd. Finally, UBS Group boosted their price objective on Pediatrix Medical Group from $16.
50 to $18.50 and gave the company a “neutral” rating in a research note on Friday, February 21st. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company.
According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $17.08. Pediatrix Medical Group Stock Performance Shares of MD stock opened at $13.
11 on Tuesday. The stock’s 50-day moving average price is $14.39 and its 200 day moving average price is $13.
83. The company has a quick ratio of 1.42, a current ratio of 1.
60 and a debt-to-equity ratio of 0.81. The stock has a market capitalization of $1.
12 billion, a PE ratio of -10.92, a price-to-earnings-growth ratio of 1.74 and a beta of 1.
32. Pediatrix Medical Group, Inc. has a 52-week low of $6.
62 and a 52-week high of $17.67. Pediatrix Medical Group ( NYSE:MD – Get Free Report ) last announced its earnings results on Thursday, February 20th.
The company reported $0.49 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.
12. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.
92%. The company had revenue of $502.36 million for the quarter, compared to the consensus estimate of $486.
22 million. As a group, equities research analysts forecast that Pediatrix Medical Group, Inc. will post 1.
38 EPS for the current year. Pediatrix Medical Group Profile ( Free Report ) Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.
See Also Five stocks we like better than Pediatrix Medical Group Insider Buying Explained: What Investors Need to Know Options Activity Points to More Volatility for Palantir Stock How to Calculate Return on Investment (ROI) NVIDIA Stock: Oversold, Undervalued — How Low Can It Go? 3 Ways To Invest In Coffee, Other Than Drinking It MicroStrategy Sees Insider Buy-Sell Action in Q1 Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter ..
